Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins-Reference-Cited by-同舟云学术

Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins

Published:2015-07 Issue: Volume:100 Page:210-222
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Jiménez Carmen^ORCID,Ellahioui Younes,Álvarez Raquel,Aramburu Laura,Riesco Alejandra,González Myriam,Vicente Alba,Dahdouh Abdelaziz,Ibn Mansour Ahmed,Jiménez Carlos^ORCID,Martín Diego,Sarmiento Rogelio G.,Medarde Manuel,Caballero Esther,Peláez Rafael

Funder

Consejería de Educación de la Junta de Castilla y León

Spanish AECID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference67 articles.

1. http://www.who.int/mediacentre/factsheets/fs297/en/.

2. Cancer drug resistance: an evolving paradigm;Holohan;Nat. Rev. Cancer,2013

3. Antineoplastic agents. 84. Isolation and structure of combretastatin;Pettit;Can. J. Chem.,1982

4. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study;Lin;Mol. Pharmacol.,1988

5. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents;Penthala;Eur. J. Med. Chem.,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and bioevaluation of 1 h -pyrrolo[3,2- c ]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-01-14

2. New Schiff Base–TMB Hybrids: Design, Synthesis and Antiproliferative Investigation as Potential Anticancer Agents;Symmetry;2023-02-28

3. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors;European Journal of Medicinal Chemistry;2023-02

4. Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect;Advanced Drug Delivery Reviews;2022-04

5. Designing anticancer combretastatin A-4 analogues with aggregation-induced emission characteristics;Science China Chemistry;2022-03-14